

The Unseen Emergency: Understanding Ocular Involvement in SJS/TEN
When we talk about Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), the immediate focus is often on the severe and visible impact on the skin. However, SJS/TEN is a mucocutaneous condition, meaning it attacks the mucous membranes just as aggressively. For up to 80% of patients, the eyes are directly on the front lines of this immune response. Because SJS/TEN is incredibly rare, bringing awareness to the different clinical topics within the disease is ess
Mar 273 min read


When a Rare Disease Is Missed: Misdiagnosis of Stevens–Johnson Syndrome and Why It Matters
Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare, life-threatening reactions, most often triggered by medications. Despite their severity, early SJS/TEN is frequently misdiagnosed, delaying withdrawal of the offending drug and appropriate care. For a condition where hours and days matter, misrecognition can significantly worsen outcomes. As we recognize Rare Disease Month, it is important to examine why SJS/TEN is so often missed, what it is common
Feb 183 min read


Fueling the Fight: Nutrition and Physical Recovery After SJS/TEN
Recovery from Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) does not end when the skin stops blistering. For many survivors, the weeks and months after hospitalization are defined by rebuilding strength, healing wounds, and restoring physical function. Two pillars of this recovery, nutrition and physical rehabilitation, are often under-discussed, yet they are central to healing. This post explores what research and clinical guidance tell us about how f
Jan 84 min read


Prevention Starts with Awareness: Reducing the Risk of Severe Drug Reactions
Every October, Canadian Patient Safety Week reminds us of the importance of preventing harm before it happens. For rare but serious conditions like Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), prevention means reducing risk for everyone: by improving drug safety, recognizing early signs, and responding quickly when reactions occur. While we cannot always predict who will develop them, greater awareness can help reduce the risk. Understanding the Risk
Nov 18, 20253 min read


Recognizing and Addressing SJS/TEN in Skin of Color
Stevens–Johnson yndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, life-threatening skin reactions that can affect anyone....
Oct 9, 20252 min read


August Is Global SJS Awareness Month: The Power of Awareness and What You ShouldKnow
Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare but devastating drug reactions that can quickly escalate...
Aug 14, 20253 min read
